Patent · US Active

Compositions and methods for the treatment of fungal infections

US11197909B2 · kind B2 · utility

4Cited by

26References

23Claims

0Family size

Assignee

Cidara Therapeutics, Inc. · US

Inventors

Kenneth BARTIZAL · Village of La Jolla, US
Paul DARUWALA · Del Mar, US
David Anthony Hughes · Los Altos Hills, US
Martin Patrick Hughes · Spokane, US
Navdeep B. Malkar · Cary, US
Balasingam Radhakrishnan · Chapel Hill, US
Anuradha Vaidya · Raleigh, US

Key dates

Filing date	Jul 11, 2018
Grant date	Dec 14, 2021
Priority date	—
Expiry date	Jul 14, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0019
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.